Bloom Science and Biose industrie have entered an agreement for the manufacture development of Bloom Science’s novel epilepsy Live Biotherapeutic Product (LBP).  Bloom is targeting rare epileptic syndromes with orally-delivered pharmaceutical compositions of specific combined strains of naturally-occurring microbes. These microbes are designed to act on the GABAergic system. Under the agreement, Biose industrie will develop a manufacturing process at its industry leading development and...